These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17697807

  • 1. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
    Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T, Node K.
    Am J Cardiol; 2007 Aug 15; 100(4):569-74. PubMed ID: 17697807
    [Abstract] [Full Text] [Related]

  • 2. Total and high molecular weight adiponectin in patients with coronary artery disease.
    El-Menyar A, Rizk N, Al Nabti AD, Hassira SA, Singh R, Abdel Rahman MO, Suwaidi JA.
    J Cardiovasc Med (Hagerstown); 2009 Apr 15; 10(4):310-5. PubMed ID: 19430341
    [Abstract] [Full Text] [Related]

  • 3. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
    Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, Inukai T, Nakano Y.
    Diabetes; 2006 Jul 15; 55(7):1954-60. PubMed ID: 16804063
    [Abstract] [Full Text] [Related]

  • 4. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
    Liang KW, Lee WJ, Lee WL, Ting CT, Sheu WH.
    Clin Chim Acta; 2009 Jul 15; 405(1-2):114-8. PubMed ID: 19397903
    [Abstract] [Full Text] [Related]

  • 5. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.
    Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, Sinning C, Tzikas S, Keller T, Genth-Zotz S, Lackner KJ, Münzel TF, Blankenberg S.
    Eur Heart J; 2008 Mar 15; 29(5):649-57. PubMed ID: 18263867
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
    Krecki R, Drozdz J, Szcześniak P, Orszulak-Michalak D, Krzemińska-Pakuła M.
    Kardiol Pol; 2008 Nov 15; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
    [Abstract] [Full Text] [Related]

  • 8. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M, Tabuchi T, Minami Y, Takahashi Y, Itoh T, Nakamura M.
    Clin Ther; 2009 Oct 15; 31(10):2113-25. PubMed ID: 19922882
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men.
    Seino Y, Hirose H, Saito I, Itoh H.
    Metabolism; 2009 Mar 15; 58(3):355-60. PubMed ID: 19217451
    [Abstract] [Full Text] [Related]

  • 11. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
    Seino Y, Hirose H, Saito I, Itoh H.
    Metabolism; 2007 Nov 15; 56(11):1493-9. PubMed ID: 17950099
    [Abstract] [Full Text] [Related]

  • 12. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K, Aso Y, Mittermayer F, Inukai T, Brix J, Schernthaner G.
    Transl Res; 2009 Apr 15; 153(4):199-203. PubMed ID: 19304279
    [Abstract] [Full Text] [Related]

  • 13. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587
    [Abstract] [Full Text] [Related]

  • 14. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease.
    Hung MJ, Cherng WJ, Yang NI, Cheng CW, Li LF.
    Am J Cardiol; 2005 Dec 01; 96(11):1484-90. PubMed ID: 16310426
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma adiponectin: a predictor of coronary heart disease in hemodialysis patients--a Japanese prospective eight-year study.
    Takemoto F, Katori H, Sawa N, Hoshino J, Suwabe T, Nakanishi S, Arai S, Fukuda S, Kodaka K, Shimada M, Yamazaki C, Yokoyama K, Nakano Y, Funahashi T, Ubara Y, Yamada A, Takaichi K, Uchida S.
    Nephron Clin Pract; 2009 Dec 01; 111(1):c12-20. PubMed ID: 19052467
    [Abstract] [Full Text] [Related]

  • 17. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 18. Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study.
    Sposito AC, Lemos PA, Santos RD, Hueb W, Vinagre CG, Quintella E, Carneiro O, Chapman MJ, Ramires JA, Maranhão RC.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2225-32. PubMed ID: 15193684
    [Abstract] [Full Text] [Related]

  • 19. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome.
    Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T.
    Diabetes Care; 2006 Jun 16; 29(6):1357-62. PubMed ID: 16732021
    [Abstract] [Full Text] [Related]

  • 20. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma.
    Horiguchi A, Ito K, Sumitomo M, Kimura F, Asano T, Hayakawa M.
    Jpn J Clin Oncol; 2008 Feb 16; 38(2):106-11. PubMed ID: 18245516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.